Choate Investment Advisors »

Aligos Therapeutics shares owned by Choate Investment Advisors

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Choate Investment Advisors from 13F filings

Historical chart of Choate Investment Advisors investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Choate Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Choate Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $18k 24k 0.75
2023-06-30 $23k 24k 0.97

More positions owned by Choate Investment Advisors

Ishares Tr Core S&p500 Etf (IVV)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr National Mun Etf (MUB)
Ishares Core Msci Emkt (IEMG)
Spdr Ser Tr Spdr S&p 500 Etf (SPYX)
Apple (AAPL)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Microsoft Corporation (MSFT)
Chase Corporation
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Us Aggbd Et (AGG)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Home Depot (HD)

View all positions for Choate Investment Advisors

Top funds holding Aligos Therapeutics

Alyeska Investment Group
EcoR1 Capital
Vivo Capital
Altitude Crest Partners
Versant Venture Management
Tang Capital Management
Baker Bros. Advisors
Hillhouse Capital Advisors
Opaleye Management
Newtyn Management
Bank of America Corporation
Vanguard Group
Charles Schwab Investment Management
Millennium Management
Procyon Private Wealth Partners

View all funds holding Aligos Therapeutics